Replies to post #85122 on BioAmber Inc fka BIOAQ

[Brucebannerr]

If it was not hidden then the owners of the debt ridden shell would know what it was and who was making it . Confidential ? Then it's hidden in some fantasy world.

con·fi·den·tial


intended to be kept secret.
"confidential information"
Similar:
private
personal
intimate
privileged
quiet
secret
top secret
sensitive
classified
restricted
nonpublic
unofficial
off the record
not for publication
not for circulation
not to be made public
not to be disclosed
under wraps
unrevealed
undisclosed
unpublished
sub rosa
hush-hush
mum
privy
Opposite:
public
on the record
indicating that what one says is private or secret.
"
entrusted with private or restricted information.

[Hole shot King]

Hay CSCS have you been Following DSM .... that's a lot of dividends


DSM commences €1 billion share buy-back and announces regular repurchase to cover share plans and stock dividend
Heerlen, NL, 14 Mar 2019 08:00 CET

Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, today announces that it will commence the repurchase of ordinary shares with an aggregate market value of €1 billion starting 1 April 2019, with the intention to reduce its issued capital, as first announced on 14 February 2019.

In addition, DSM announces the repurchase of 2,600,000 ordinary shares: 800,000 ordinary shares to cover commitments under share-based compensation plans and 1,800,000 ordinary shares to cover commitments for stock dividend, equivalent to approximately €0.25 billion based on the closing price of the DSM ordinary share on Euronext Amsterdam on 13 March 2019.

The share buy-back will be executed within the limitations of the authority granted to the Managing Board by the Annual General Meeting (AGM). Based on the closing price of the DSM ordinary share on Euronext Amsterdam on 13 March 2019 this share buy-back would be equivalent to approximately €1.25 billion and the total number of ordinary shares to be repurchased under this program represents approximately 7.1% of ordinary shares issued.

DSM has signed a Discretionary Management Agreement with a bank to commence the execution of the share buy-back program and to make trading decisions under the Agreement independently of DSM.

In accordance with regulations DSM will inform the market about the progress made in the execution of this program through weekly press releases. The share repurchase program is anticipated to continue into Q2 2020.


https://www.dsm.com/corporate/news/news-archive/2019/08-19-dsm-commences-euro-1-billion-share-buy-back-and-announces-regular-repurchase-to-cover-share-plans-and-stock-dividend.html

DSM - repurchase of shares (23-27 September 2019)
Heerlen, NL, 01 Oct 2019 09:00 CEST

Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has repurchased 162,212 of its own shares in the period from 23 September 2019 up to and including 27 September 2019 at an average price of €106.77. This is in accordance with the repurchase announced on 14 March 2019, covering the intended reduction of issued capital as well as commitments under share-based compensation plans and for stock dividends. The consideration of this repurchase was €17.3 million.

The total number of shares repurchased under this program to date is 4,407,509 shares for a total consideration of €464.8 million.

[TenKay]

An unregistered sale of equity of an SEC reporting company is required to be disclosed.

It can not be kept “confidential”.